Riekkinen M, Riekkinen P
Department of Neuroscience and Neurology, University of Kuopio, Finland.
Neuroreport. 1997 Feb 10;8(3):699-703. doi: 10.1097/00001756-199702100-00024.
We investigated the effect of nicotine, a nicotinic agonist, and D-cycloserine (DCS, a partial glycine-B agonist of the N-methyl-D-aspartate (NMDA) receptor complex) on aging-induced defects of water maze (WM) spatial navigation in rats. Nicotine (0.3 mg kg-1, s.c.) or DCS (10 mg kg-1, i.p.) enhanced acquisition of the WM task. A combination of subthreshold doses of nicotine (0.1 mg kg-1) and DCS (3 mg kg-1) improved WM acquisition. A subthreshold dose of a competitive NMDA antagonist, CPP (1 mg kg-1), blocked the effect of nicotine (0.3 mg kg-1) on WM acquisition. A nicotine antagonist, mecamylamine (10 mg kg-1), impaired WM acquisition and had no effect on retention, but did not block the effect of DCS 10 mg kg-1. The results suggest that nicotine and DCS synergistically enhance spatial navigation in aged rats.
我们研究了尼古丁(一种烟碱激动剂)和D-环丝氨酸(DCS,N-甲基-D-天冬氨酸(NMDA)受体复合物的部分甘氨酸-B激动剂)对衰老诱导的大鼠水迷宫(WM)空间导航缺陷的影响。尼古丁(0.3毫克/千克,皮下注射)或DCS(10毫克/千克,腹腔注射)可增强WM任务的习得。阈下剂量的尼古丁(0.1毫克/千克)和DCS(3毫克/千克)联合使用可改善WM习得。阈下剂量的竞争性NMDA拮抗剂CPP(1毫克/千克)可阻断尼古丁(0.3毫克/千克)对WM习得的作用。尼古丁拮抗剂美加明(10毫克/千克)损害WM习得且对记忆保持无影响,但不阻断10毫克/千克DCS的作用。结果表明,尼古丁和DCS协同增强老年大鼠的空间导航能力。